Press Release - February 03, 2023 Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials Read More More Press Releases
Press Release - November 30, 2022 Personalis and UCSF to Study Clinical Utility of ctDNA for Treatment Response in Colorectal Cancer Read More More Press Releases
Press Release - November 07, 2022 Personalis Presents Data from New Platform Features at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting Read More More Press Releases
Press Release - October 31, 2022 Personalis Grows Leadership Team with Appointment of Christopher Hall as Senior Vice President and Head, Diagnostics Business Read More More Press Releases
Press Release - October 04, 2022 Personalis Forms Research Collaboration to Better Predict Immunotherapy Response for Gastroesophageal Cancer Read More More Press Releases
Press Release - August 30, 2022 Personalis to Present at the Morgan Stanley 20th Annual Global Healthcare Conference Read More More Press Releases
Press Release - August 17, 2022 Personalis Adds New MRD Patent Covering the Combination of Tumor-Informed and Database-Derived Content to Patent Infringement Complaint Against Foresight Diagnostics Read More More Press Releases
Press Release - August 16, 2022 Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Read More More Press Releases
Press Release - August 15, 2022 Personalis in Partnership with BC Cancer to Assess Clinical and Economic Benefits of ctDNA for Colorectal and Pancreatic Cancers Read More More Press Releases
